<DOC>
	<DOCNO>NCT01801319</DOCNO>
	<brief_summary>This randomize , placebo-controlled double-blind cross-over trial evaluate safety , efficacy , daily functioning , health-related quality life Subcallosal Cingulate Gyrus Deep Brain Stimulation ( SCG DBS ) participants Treatment-Resistant Depression ( TRD ) . A total 40 eligible participant randomize four treatment sequence ( 10 participant per sequence ) . Each participant treat 6-month period active sham stimulation participant attend psychiatrist blind treatment allocation .</brief_summary>
	<brief_title>A Clinical Evaluation Subcallosal Cingulate Gyrus Deep Brain Stimulation Treatment-Resistant Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Treatment-Resistant</mesh_term>
	<criteria>1 . Men woman ( nonpregnant ) age 2170 year ; 2 . Diagnosed nonpsychotic major depressive disorder , single recurrent episode DSMIVTR criterion ; 3 . First episode onset age 45 ; 4 . Current episode &gt; 12 month duration ; 5 . In current episode : Documented resistance ( i.e . persistence major depressive episode ) minimum 4 adequate depression treatment least 3 different treatment category ( e.g . SSRI 's , SNRI 's , TCA 's , MAOinhibitors , Mirtazipine , Nefazodone , Trazodone , Bupropion , lithium augmentation , thyroid augmentation , ECT ) ; Adequacy treatment define score least 3 accord amend Antidepressant Treatment History Form ( ATHF ) criteria ; 6 . Hamilton Depression Rating Scale ( HDRS ) &gt; 20 3 separate baseline visit , rat 2 separate psychiatrist , Baseline 2 Baseline 3 HDRS score improve â‰¥ 25 % ; 1 . A diagnosis bipolar I bipolar II disorder DSMIVTR criterion ; 2 . Meets criteria borderline antisocial personality disorder last 12 month DSMIVTR criterion , derive Cluster B Personality . 3 . In current depressive episode , diagnose General Anxiety Disorder ( GAD ) define DSMIVTR , GAD primary diagnosis ; 4 . Has intracranial Central Nervous System ( CNS ) disease impairs motor , sensory cognitive function require intermittent chronic medication ( e.g. , Parkinson 's Disease , migraine , stroke , Huntington 's , head trauma , etc . ) exception nonmigraine headache ; 5 . Has diagnose fibromyalgia current condition require chronic pain narcotic usage ( e.g . morphine , methadone ) ; 6 . Has currently diagnose chronic fatigue syndrome ; 7 . Substantial suicidal risk define ( 1 ) current plan intent , ( 2 ) clinician judgment clear immediate intent selfharm , ( 3 ) 3 suicide attempt within last 12 month ; 8 . Comorbid obsessive compulsive disorder , posttraumatic stress disorder , panic disorder , bulimia anorexia nervosa previously present , must remission 6 month define DSMIVTR criterion , derive MINI ; 9 . Alcohol , medication , illegal substance dependence within last 12 month ; 10 . Advanced cardiovascular disease render anesthesia surgery unsafe determine neurosurgeon ; 11 . Plans use diathermy ; 12 . Have metallic implant brain aneurysm clip cochlear implant ; 13 . Currently participate another investigational device , drug surgical trial .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>major depressive disorder ( MDD )</keyword>
	<keyword>deep brain stimulation ( DBS )</keyword>
	<keyword>subcallosal cingulate gyrus</keyword>
	<keyword>Therapy-Resistant Depression</keyword>
	<keyword>Electrical Stimulation Brain</keyword>
	<keyword>Brain Stimulation , Deep</keyword>
</DOC>